Showing 8201-8220 of 8668 for: Cochrane Systematic Reviews Back
- Treatment for Lambert‐Eaton myasthenic syndrome
Cochrane Systematic Reviews, 16-Feb-2011
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission
- Treatment for leiomyosarcoma and leiomyoma in children with HIV infection
Cochrane Systematic Reviews, 14-Apr-2010
Smooth muscle tumour (SMT) composed of leiomyoma and leiomyosarcoma recently has been described in many HIV-infected children. Leiomyosarcoma has become the second most frequent malignancy in children with HIV infection or other immunodeficiency diseases
- Treatment for meralgia paraesthetica
Cochrane Systematic Reviews, 12-Dec-2012
Meralgia paraesthetica is a clinical syndrome for which a number of treatments are in common use, including conservative measures, injection of corticosteroid with local anaesthetic and surgery. We aimed to examine the evidence for the relative efficacy o
- Treatment for Methaqualone dependence in adults
Cochrane Systematic Reviews, 27-Mar-2008
Methaqualone is a potent quinazoline, a class of sedative-hypnotics, that has a high potential for abuse. While the oral use of methaqualone (Quaalude, Mandrax) has waned in western countries since the mid-late 1980's, the practice of smoking methaqualone
- Treatment for mitochondrial disorders
Cochrane Systematic Reviews, 18-Apr-2012
Mitochondrial respiratory chain disorders are the most prevalent group of inherited neurometabolic diseases. They present with central and peripheral neurological features usually in association with other organ involvement including the eye, the heart, t
- Treatment for osteoporosis in people with ß-thalassaemia
Cochrane Systematic Reviews, 3-Mar-2016
Osteoporosis is a systemic skeletal disease characterized by low bone mass and micro-architectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. Osteoporosis represents an important cause of morb
- Treatment for paraneoplastic neuropathies
Cochrane Systematic Reviews, 12-Nov-2012
It is not unusual to observe peripheral nervous system involvement in people with tumours outside the nervous system. Any part of the peripheral nervous system can be involved, from sensory and motor neurons to nerve roots and plexuses, from distal trunks
- Treatment for periodic paralysis
Cochrane Systematic Reviews, 28-Apr-2008
Primary periodic paralyses are rare inherited muscle diseases characterised by episodes of flaccid weakness affecting one or more limbs, lasting several hours to several days, caused by mutations in skeletal muscle channel genes.
- Treatment for peritoneal dialysis-associated peritonitis
Cochrane Systematic Reviews, 20-Apr-2014
Peritonitis is a common complication of peritoneal dialysis (PD) that is associated with significant morbidity including death, hospitalisation, and need to change from PD to haemodialysis. Treatment is aimed to reduce morbidity and recurrence. This is an
- Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, and skin changes) syndrome
Cochrane Systematic Reviews, 13-Jun-2012
POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome is a rare cause of demyelinating and axonal mixed neuropathy with monoclonal plasma cell proliferative disorder and multiorgan involvement. The pathogenesis of POEM
- Treatment for postpolio syndrome
Cochrane Systematic Reviews, 12-May-2015
Postpolio syndrome (PPS) may affect survivors of paralytic poliomyelitis and is characterised by a complex of neuromuscular symptoms leading to a decline in physical functioning. The effectiveness of pharmacological treatment and rehabilitation management
- Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery
Cochrane Systematic Reviews, 6-Feb-2015
In people with haemophilia or other congenital bleeding disorders undergoing surgical interventions, haemostatic treatment is needed in order to correct the underlying coagulation abnormalities and minimise the bleeding risk. This treatment varies accordi
- Treatment for primary postpartum haemorrhage
Cochrane Systematic Reviews, 12-Feb-2014
Primary postpartum haemorrhage (PPH) is one of the top five causes of maternal mortality in both developed and developing countries.
- Treatment for recurrent vulvovaginal candidiasis (thrush)
Cochrane Systematic Reviews, 10-Jan-2022
Recurrent vulvovaginal candidiasis (RVVC) affects up to 5% of women. No comprehensive systematic review of treatments for RVVC has been published.
- Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
Cochrane Systematic Reviews, 27-Mar-2011
Motor neuron disease (MND), also known as amyotrophic lateral sclerosis, is a progressive, neurodegenerative condition which may cause dysphagia, as well as limb weakness, dysarthria, emotional lability and respiratory failure. Since normal salivary produ
- Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 15-Feb-2012
Spasticity commonly affects patients with motor neuron disease. It is likely to contribute to worsening muscle dysfunction, increased difficulty with activities of daily living and deteriorating quality of life. This is an update of a review first publish
- Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes
Cochrane Systematic Reviews, 23-Oct-2014
Hereditary ataxia syndromes can result in significant speech impairment, a symptom thought to be responsive to treatment. The type of speech impairment most commonly reported in hereditary ataxias is dysarthria. Dysarthria is a collective term referring t
- Treatment for superficial infusion thrombophlebitis of the upper extremity
Cochrane Systematic Reviews, 16-Nov-2015
Although superficial thrombophlebitis of the upper extremity represents a frequent complication of intravenous catheters inserted into the peripheral veins of the forearm or hand, no consensus exists on the optimal management of this condition in clinical
- Treatment for superficial thrombophlebitis of the leg
Cochrane Systematic Reviews, 25-Feb-2018
The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. While improving or relieving the local painful symptoms, treatment should aim at preventing venous thromboembolism (VTE), which might complicate the natural his
- Treatment for telangiectasias and reticular veins
Cochrane Systematic Reviews, 12-Oct-2021
Telangiectasias (spider veins) and reticular veins on the lower limbs are very common, increase with age, and have been found in 41% of women. The cause is unknown and the patients may be asymptomatic or can report pain, burning or itching. Treatments inc
